| Structure | Chemical Name | CAS | MF |
|
(R)-KETOPROFEN
|
|
C16H14O3
|
|
(R)-(-)-KETOPROFEN, [3H(G)]
|
|
C16O3T14
|
|
RizlaVelinTissues200MmX200Mm
|
|
|
|
|
RizlaVelinTissues150MmX150Mm
|
|
|
|
|
RizlaVelinTissues300MmX300Mm
|
|
|
|
|
RJP57-1 protein
|
|
|
|
|
RIZ protein
|
|
|
|
|
RJ100P (Rhodium Phosphate) This phosphate based concentrate has been specially developed for decorative applications. It will produce bright, white lustrous deposits at thicknesses below 0.5. The recommended maximum thickness is 1.
|
|
|
|
|
Rizzoli IOR protocol
|
|
|
|
RJR-2429 2HCL
|
91556-75-1
|
C12H16N2
|
|
RL 236
|
153901-48-5
|
C21H22ClN5S
|
|
RL 218
|
153901-56-5
|
C22H23ClN6
|
|
|
R15K, HIV-1 Inhibitory Peptide
|
|
|
|
RJR-2403 (oxalate)
|
220662-95-3
|
C12H16N2O4
|
|
|
RKIN1 protein
|
|
|
|
|
RKI1 protein
|
|
|
|
|
Rjs protein
|
|
|
|
|
RJ21S (Rhodium Sulphate)
|
|
|
|
|
(5β,9α,10α,13R)-Labd-8(17)-en-15-oic acid
|
|
|
|
|
[(13R)-Labda-7,14-dien-13-yl]6-deoxy-β-D-galacto-hexopyranoside
|
|
|
|
(13R)-Labd-8(17)-ene-15,18-dioic acid dimethyl ester
|
13346-06-0
|
C22H36O4
|
|
|
[(13R)-Labda-7,14-dien-13-yl]3-O,4-O-[(2H6)isopropylidene]-β-D-fucopyranoside
|
|
|
|
|
[5β,9α,10α,13R,(-)]-Labda-8(17)-ene-15,19-dioic acid
|
|
|
|
|
[(13R)-Labda-7,14-dien-13-yl]6-deoxy-α-L-manno-hexopyranoside
|
|
|
|
|
(13R)-Labda-8(17),14-diene-7α,13-diol
|
|
|
|
|
(4R,5β,9β,10α)-Labda-8(17)-ene-15,18-diol
|
|
|
|
|
(4R,5β,9β,10α)-Labda-8(17)-ene-15,18-dioic acid
|
|
|
|
|
(5β,9α,10α,13R)-Labda-7,14-diene-2,13-diol
|
|
|
|
|
(5β,9R,10α)-Labda-8(17),14-diene-13-ol
|
|
|
|
|
[5β,9α,10α,13R,(-)]-Labda-8(17),14-diene-13,19-diol
|
|
|
|
|
[5β,9α,10α,13R,(-)]-Labda-8(17)-ene-15,19-diol
|
|
|
|
|
(13R)-Labdan-14-ene-2α,8,13,18-tetrol
|
|
|
|
|
[(13R)-Labda-7,14-dien-13-yl]6-deoxy-α-L-ido-hexopyranoside
|
|
|
|
|
(8R)-Labda-13-ene-8α,15,16-triol
|
|
|
|
|
[(13R)-Labda-7,14-dien-13-yl]3-O,4-O-[(2H6)isopropylidene]-α-L-rhamnopyranoside
|
|
|
|
(13R)-Labdane-8,15-diol
|
10267-22-8
|
C20H38O2
|
|
(2R)-LacosaMide-d3
|
1217689-95-6
|
C13H18N2O3
|
|
(R)-Lactate
|
10326-41-7
|
C3H6O3
|
|
(R)-(+)-Lactamide
|
598-81-2
|
C3H7NO2
|
|
|
r-Lactamase
|
|
|
|
Amygdalin
|
29883-15-6
|
C20H27NO11
|
|
|
RKKFGESEKTKTKEFL
|
|
|
|
|
rLALF
|
|
|
|
(24R)-5α-Lanost-8-ene-2α,3β,24,25-tetraol
|
64971-21-7
|
C30H52O4
|
|
(24R)-5α-Lanost-8-ene-2α,3β,12α,24,25-pentol 2-[3-hydroxy-5-[(2-methoxy-2-oxoethyl)amino]-3-methyl-5-oxopentanoate]
|
64971-23-9
|
C39H65NO10
|
|
(20R)-5α-Lanosta-7,9(11)-diene-3β,18,20-triol 3,18-diacetate
|
24041-72-3
|
C34H54O5
|
|
(24R)-5α-Lanost-8-ene-2α,3β,12α,24,25-pentol 3-[3-hydroxy-5-[(2-methoxy-2-oxoethyl)amino]-3-methyl-5-oxopentanoate]
|
69770-64-5
|
C39H65NO10
|
|
(22R)-5α-Lanosta-8,24-diene-3β,22-diol
|
35963-37-2
|
C30H50O2
|
|
(R)-Lanoconazole
|
133267-38-6
|
C14H10ClN3S2
|
|
R-(+)-Lansoprazole
|
138530-94-6
|
C16H14F3N3O2S
|
|
(25R)-3α-(L-Arabinopyranosyloxy)-5β-spirostan-2β-ol
|
5491-96-3
|
C32H52O8
|
|
|
RKKRRQRRR-AMIDE
|
|
|
|
(R)-(7-Lauroyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphaheptacosyl)trimeth ylammonium 4-oxide
|
82617-24-1
|
|
|
|
Rlb1 protein
|
|
|
|
(R)-()-JWH 073 N-(3-hydroxybutyl) metabolite
|
|
C23H21NO2
|
|
|
Rlc1 protein
|
|
|
|
|
rLDH
|
|
|
|
|
50R-LC-RA8 50UL SYRINGE
|
|
|
|
|
250R-LC-RA8 250UL SYRINGE
|
|
|
|
|
10R-LC-RA6 10UL SYRINGE
|
|
|
|
|
500R-LC-RA8 500UL SYRINGE
|
|
|
|
|
25R-LC-RA8 25UL SYRINGE
|
|
|
|
|
100R-LC-RA8 100UL SYRINGE
|
|
|
|
|
（R）－4－（l,5－Dimethyl－3－oxo－4 －hexenyl）benzoic acid
|
|
C15H18O3
|
|
|
50R-LC 50UL SYRINGE
|
|
|
|
|
250R-LC 250UL SYRINGE
|
|
|
|
|
5R-LC 5UL SYRINGE
|
|
|
|
|
100R-LC 100UL SYRINGE
|
|
|
|
|
10R-LC 10UL SYRINGE
|
|
|
|
|
25R-LC 25UL SYRINGE
|
|
|
|
|
500R-LC 500UL SYRINGE
|
|
|
|
|
RLD-1 protein
|
|
|
|
|
RLDRAMINE^TM TRAPPING PACKET LARGE
|
|
|
|
|
RK-1 peptide
|
|
|
|
|
RK9, p17 Gag (20 - 28)
|
|
|
|
(22R)-Kopsan-22-ol
|
24992-91-4
|
C20H24N2O
|
|
(R)-Lercanidipine Hydrochloride
|
187731-34-6
|
C36H42ClN3O6
|
|
|
(R)-Lercanidipine-d3 Hydrochloride
|
|
C36H39D3ClN3O6
|
|
|
R-Lercanidipine
|
|
C36H41N3O6
|
|
|
R-Lercanidipine-d3
|
1217976-64-1
|
C36H38D3N3O6
|
|
|
RkpG protein
|
|
|
|
|
RkpH protein
|
|
|
|
|
RkpJ protein
|
|
|
|
|
R-LEVAMISOLE TARTRATE
|
|
|
|
(2R)-L-gamma-Glutamyl-3-((2-((bis(bis(2-chloroethyl)amino)phosphinyl)oxy) ethyl)sulfonyl)- L-alanyl-2-phenylglycine
|
158382-37-7
|
C26H40Cl4N5O10PS
|
|
|
rlf-L-myc fusion protein
|
|
|
|
|
RLF98 protein
|
|
|
|
|
RLF protein
|
|
|
|
RLH 033
|
157097-10-4
|
C25H31ClN2O4
|
|
|
RK-1 protein
|
|
|
|
|
RK2 protein
|
|
|
|
|
(8R)-8α-(β-L-Fucopyranosyloxy)labd-13-ene-15,16-diol
|
|
|
|
|
[R,(-)]-L-Glycerol 1,2-dibenzoate 3-(p-nitrobenzoate)
|
|
|
|
RM 06
|
126869-52-1
|
C21H32N6O6S
|
|
RM 49
|
113785-48-1
|
C16H20N4O6
|
|
(R)-Licarbazepine Acetate
|
186694-45-1
|
C17H16N2O3
|
|
R-Licarbazepine Glucuronide SodiuM Salt
|
104746-01-2
|
C21H22N2O8
|
|
|
RL-IF-1 protein
|
147095-03-2
|
|
|
(R)-linalyl acetate
|
16509-46-9
|
C12H20O2
|
|
(R)-lindenether,2,4,5,7a-tetrahydro-3,6-dimethyl-benzofuran
|
125811-37-2
|
C10H14O
|